Ishita Drugs

23
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE806D01016
  • NSEID:
  • BSEID: 524400
INR
75.50
3.43 (4.76%)
BSENSE

Dec 19

BSE+NSE Vol: 831

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -1.25% vs 25.81% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 10.24% vs 19.26% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -19.57% vs 67.60% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 15.98% vs 29.63% in Mar 2024

Compare Profit and Loss Results of Ishita Drugs
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
14.00
6.00
8.00
133.33%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
14.00
6.00
8.00
133.33%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
10.00
2.00
8.00
400.00%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
1.00
2.00
-1.00
-50.00%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
13.00
6.00
7.00
116.67%
Operating Profit (PBDIT) excl Other Income
1.00
0.00
1.00
0%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
1.00
0.00
1.00
0%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
1.00
0.00
1.00
0%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
1.00
0.00
1.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
1.00
0.00
1.00
0%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
0.00
0.00
0.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
6.00
2.00
4.00
200.00%
Profit Available for appropriations
7.00
3.00
4.00
133.33%
Appropriations
7.00
3.00
4.00
133.33%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
2.9
1.97
0.93
47.21%
Profit And Loss - Net Sales
Net Sales 15.00 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -1.25% vs 25.81% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1.00 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 10.24% vs 19.26% in Mar 2024

Profit And Loss - Interest
Interest 0.07 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -19.57% vs 67.60% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 0.87 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 15.98% vs 29.63% in Mar 2024